Medicine recalls
|
| |
| The United States: Golden State Medical Supply, Inc. issues a voluntary nationwide recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets due to a label mix-up |
| |
The US Food and Drug Administration (FDA) announces that Golden State Medical Supply, Inc. (GSMS, Inc.) has initiated a voluntary recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets because a report was received that a bottle containing Clopidogrel 75mg Tablets produced with lot# GS046745 was mislabeled as Atenolol 25mg Tablets. This voluntary recall only affects products with lot# GS046745. No other clopidogrel or atenolol products marketed by GSMS, Inc. are impacted. Both products are being recalled out of abundance of caution.
Patients who suddenly stop taking atenolol, as would happen if clopidogrel were misplaced in the atenolol-labeled bottle, are at increased risk for ischemic (angina, myocardial infarction), hypertensive and arrhythmic adverse events relating to rapid withdrawal of beta antagonism. Further, patients who are on atenolol are frequently on concomitant anticoagulant and antiplatelet medications and would be at increased risk for bleeding if clopidogrel were added to the regimen. To date, GSMS, Inc. has not received any reports of adverse events related to the use of the products as part of this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/golden-state-medical-supply-inc-issues-voluntary-nationwide-recall-atenolol-25-mg-tablets-and
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product manufactured by GSMS, Inc.
Ends/Friday, Sep 30, 2022
Issued at HKT 14:00
|
| |
